Skip to content

Personalized Strategies for Cardiovascular and Cerebrovascular Disease Prevention in the Chinese Population: A Prospective Cohort Study Based on Nutritional and Lifestyle Assessments

Personalized Strategies for Cardiovascular and Cerebrovascular Disease Prevention in the Chinese Population: A Prospective Cohort Study Based on Nutritional and Lifestyle Assessments

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104060
Enrollment
Unknown
Registered
2025-06-10
Start date
2025-07-14
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular and Cerebrovascular Diseases

Interventions

Observation group:None

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age > 18; 2.Those who voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Those assessed by the study to have diseases that may affect study compliance or data collection, including but not limited to dementia, severe mental illness, loss of expression or behavioral disorders; 2.Those who are assessed by the investigator to be unsuitable for participation in this study or unable to complete long-term follow-up.

Design outcomes

Primary

MeasureTime frame
Cardiovascular and cerebrovascular diseases: including hypertension, stroke, myocardial infarction, heart failure, atrial fibrillation, and peripheral vascular diseases.;

Secondary

MeasureTime frame
Metabolic diseases: obesity, diabetes, dyslipidemia, hyperuricemia, hyperhomocysteinemia, osteoporosis, fatty liver disease related to metabolic dysfunction, cirrhosis;;Chronic kidney disease;Malignant tumors;All-cause death;Mental illnesses: depression, anxiety, dementia, sleep disorders;Gastrointestinal diseases: inflammatory bowel disease, irritable bowel syndrome;Weakness or frailty syndrome;

Countries

China

Contacts

Public ContactJianping Li

Peking University First Hospital

13521531013@163.com+86 10 83575728

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026